These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21846292)

  • 1. Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease.
    Duijvestein M; Molendijk I; Roelofs H; Vos AC; Verhaar AP; Reinders ME; Fibbe WE; Verspaget HW; van den Brink GR; Wildenberg ME; Hommes DW
    Cytotherapy; 2011 Oct; 13(9):1066-73. PubMed ID: 21846292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.
    Dulai PS; Siegel CA; Colombel JF; Sandborn WJ; Peyrin-Biroulet L
    Gut; 2014 Dec; 63(12):1843-53. PubMed ID: 24970900
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of azathioprine and infliximab on mesenchymal stem cells derived from the bone marrow of rats in vitro.
    Huang HR; Zan H; Lin Y; Zhong YQ
    Mol Med Rep; 2014 Mar; 9(3):1005-12. PubMed ID: 24435621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression.
    Yang HM; Sung JH; Choi YS; Lee HJ; Roh CR; Kim J; Shin M; Song S; Kwon CH; Joh JW; Kim SJ
    Cytotherapy; 2012 Jan; 14(1):70-9. PubMed ID: 21954834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Licensing by Inflammatory Cytokines Abolishes Heterogeneity of Immunosuppressive Function of Mesenchymal Stem Cell Population.
    Szabó E; Fajka-Boja R; Kriston-Pál É; Hornung Á; Makra I; Kudlik G; Uher F; Katona RL; Monostori É; Czibula Á
    Stem Cells Dev; 2015 Sep; 24(18):2171-80. PubMed ID: 26153898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease.
    Lanzoni G; Alviano F; Marchionni C; Bonsi L; Costa R; Foroni L; Roda G; Belluzzi A; Caponi A; Ricci F; Luigi Tazzari P; Pagliaro P; Rizzo R; Lanza F; Roberto Baricordi O; Pasquinelli G; Roda E; Paolo Bagnara G
    Cytotherapy; 2009; 11(8):1020-31. PubMed ID: 19929466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy.
    Gadkari R; Zhao L; Teklemariam T; Hantash BM
    Regen Med; 2014; 9(4):453-65. PubMed ID: 25159063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells.
    Gray A; Marrero-Berrios I; Weinberg J; Manchikalapati D; SchianodiCola J; Schloss RS; Yarmush J
    Int Immunopharmacol; 2016 Apr; 33():48-54. PubMed ID: 26854576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients.
    Stio M; Martinesi M; Bruni S; Treves C; d'Albasio G; Bagnoli S; Bonanomi AG
    Int Immunopharmacol; 2006 Jul; 6(7):1083-92. PubMed ID: 16714211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro.
    de Vries HS; de Heij T; Roelofs HM; te Morsche RH; Peters WH; de Jong DJ
    Dig Dis Sci; 2012 Jun; 57(6):1604-8. PubMed ID: 22535279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation-Immunogenicity Balance, Cell Viability, and Differentiation Potential.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Gosálvez J; Roy R; Zaragoza P; Martín-Burriel I; Rodellar C
    Stem Cells Dev; 2017 Jan; 26(1):15-24. PubMed ID: 27712399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.
    He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z
    Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
    Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
    Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of tumor necrosis factor-α on immunoregulatory activities of mesenchymal stem cells in vitro and in vivo].
    Wang YQ; Li ZY; Cao XF; Wang HX; Guo ZK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):981-4. PubMed ID: 22931668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
    Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
    Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of osteogenic differentiation inducers on in vitro expanded adult mesenchymal stromal cells.
    Fiorentini E; Granchi D; Leonardi E; Baldini N; Ciapetti G
    Int J Artif Organs; 2011 Oct; 34(10):998-1011. PubMed ID: 22161283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting.
    Imperatore N; Foggia M; Patturelli M; Rispo A; Calabrese G; Testa A; Pellegrini L; Tosone G; Di Luna I; Nardone OM; Ricciolino S; Castiglione F
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1859-1868. PubMed ID: 33283312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-γ induces senescence-like characteristics in mouse bone marrow mesenchymal stem cells.
    Yang ZX; Mao GX; Zhang J; Wen XL; Jia BB; Bao YZ; Lv XL; Wang YZ; Wang GF
    Adv Clin Exp Med; 2017; 26(2):201-206. PubMed ID: 28791835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.